Evidence map›Paper›PMID 37271818›Full record

Trial reportMalaria journal2023

BOHEMIA a cluster randomized trial to assess the impact of an endectocide-based one health approach to malaria in Mozambique: baseline demographics and key malaria indicators.

Paula Ruiz-Castillo, Saimado Imputiua, Kexin Xie, Eldo Elobolobo, Patricia Nicolas, Julia Montaña, Edgar Jamisse, Humberto Munguambe, Felisbela Materrula, Aina Casellas and 6 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Malaria journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04966702 (A Phase III Cluster-randomized, Open-label, Clinical Trial to Study the Safety and Efficacy of Ivermectin Mass Drug Administration to Reduce Malaria Transmission in Two African Settings), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04966702 phase3completednot on this map

A Phase III Cluster-randomized, Open-label, Clinical Trial to Study the Safety and Efficacy of Ivermectin Mass Drug Administration to Reduce Malaria Transmission in Two African Settings

TypeinterventionalSponsorBarcelona Institute for Global HealthRan2022 to 2024Enrolled48,145ConditionsMalariaArmsAlbendazole Pill, Ivermectin Pill, Ivermectin Injectable Product
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Paula Ruiz-Castillo *ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain. paula.ruizcastillo@isglobal.org.
Saimado Imputiua *Centro de Investigaçao em Saúde de Manhiça, Manhiça, Mozambique.
Kexin XieDepartment of Statistics, Virginia Tech, Blacksburg, VA, USA.
Eldo EloboloboCentro de Investigaçao em Saúde de Manhiça, Manhiça, Mozambique.
Patricia NicolasISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Julia MontañaISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Edgar JamisseCentro de Investigaçao em Saúde de Manhiça, Manhiça, Mozambique.
Humberto MunguambeCentro de Investigaçao em Saúde de Manhiça, Manhiça, Mozambique.
Felisbela MaterrulaISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Aina CasellasISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Xinwei DengDepartment of Statistics, Virginia Tech, Blacksburg, VA, USA.
Achla MaratheNetwork Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA, USA.
Regina RabinovichISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Francisco SauteCentro de Investigaçao em Saúde de Manhiça, Manhiça, Mozambique.
Carlos Chaccour *ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Charfudin Sacoor *Centro de Investigaçao em Saúde de Manhiça, Manhiça, Mozambique.
Manhiça Health Research Centre · MZBarcelona Institute for Global Health · ESVirginia Tech · USHarvard University · USUniversitat de Barcelona · ESUniversity of Virginia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany geographical areas of sub-Saharan Africa, especially in rural settings, lack complete and up-to-date demographic data, posing a challenge for implementation and evaluation of public health interventions and carrying out large-scale health research. A demographic survey was completed in Mopeia district, located in the Zambezia province in Mozambique, to inform the Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) cluster randomized clinical trial, which tested ivermectin mass drug administration to humans and/or livestock as a potential novel strategy to decrease malaria transmission.

methodsThe demographic survey was a prospective descriptive study, which collected data of all the households in the district that accepted to participate. Households were mapped through geolocation and identified with a unique identification number. Basic demographic data of the household members was collected and each person received a permanent identification number for the study.

results25,550 households were mapped and underwent the demographic survey, and 131,818 individuals were registered in the district. The average household size was 5 members and 76.9% of households identified a male household head. Housing conditions are often substandard with low access to improved water systems and electricity. The reported coverage of malaria interventions was 71.1% for indoor residual spraying and 54.1% for universal coverage of long-lasting insecticidal nets. The median age of the population was 15 years old. There were 910 deaths in the previous 12 months reported, and 43.9% were of children less than 5 years of age.

conclusionsThe study showed that the district had good coverage of vector control tools against malaria but sub-optimal living conditions and poor access to basic services. The majority of households are led by males and Mopeia Sede/Cuacua is the most populated locality in the district. The population of Mopeia is young (< 15 years) and there is a high childhood mortality. The results of this survey were crucial as they provided the household and population profiles and allowed the design and implementation of the cluster randomized clinical trial. Trial registration NCT04966702.

Indexed as

Insecticide-Treated BednetsMalariaOne HealthAdolescentChildFamily CharacteristicsHumansMaleMosquito ControlMozambiqueBOHEMIADemographic surveyIndoor residual sprayingLong-lasting insecticidal netsMalariaMappingMopeiaMozambiquePopulation structure

Identifiers

PMID37271818
PMCPMC10239551
OpenAlexW4379284286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.